Enhancing the anti-angiogenic action of histone deacetylase inhibitors

被引：0
|
作者：
Selena Kuljaca
Tao Liu
Andrew EL Tee
Michelle Haber
Murray D Norris
Tanya Dwarte
Glenn M Marshall
机构：
[1] The University of New South Wales,The Children's Cancer Institute Australia for Medical Research
[2] Sydney Children's Hospital,The Centre for Children's Cancer and Blood Disorders
来源：
Molecular Cancer | / 6卷
关键词：
Vascular Endothelial Growth Factor; SAHA; Endothelial Cell Migration; Endothelial Cell Function; p21WAF1 Expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Enhancing the anti-angiogenic action of histone deacetylase inhibitors
    Kuljaca, Selena
    Liu, Tao
    El Tee, Andrew
    Haber, Michelle
    Norris, Murray D.
    Dwarte, Tanya
    Marshall, Glenn M.
    [J]. MOLECULAR CANCER, 2007, 6 (1)
  • [2] Apicidin is a histone deacetylase inhibitor with anti-invasive and anti-angiogenic potentials
    Kim, SH
    Ahn, S
    Han, JW
    Lee, HW
    Lee, HY
    Lee, YW
    Kim, MR
    Kim, KW
    Kim, WB
    Hong, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 315 (04) : 964 - 970
  • [3] Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
    Kristy J. Gotink
    Henk M. W. Verheul
    [J]. Angiogenesis, 2010, 13 : 1 - 14
  • [4] Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
    Gotink, Kristy J.
    Verheul, Henk M. W.
    [J]. ANGIOGENESIS, 2010, 13 (01) : 1 - 14
  • [5] In vivo monitoring of anti-angiogenic therapeutic effect of histone deacetylase inhibitors LBH589 with the help of small animal PET
    Ocker, M.
    Gahr, S.
    Maschauer, S.
    Hocke, C.
    Kuwert, T.
    Prante, O.
    [J]. ONKOLOGIE, 2010, 33 : 182 - 182
  • [6] C60(OH)22: a potential histone deacetylase inhibitor with anti-angiogenic activity
    Sun, Chengdu
    Wang, Liming
    Gao, Dan
    Pan, Yuanming
    Zhao, Yuliang
    Chen, Chunying
    Guo, Mingzhou
    [J]. NANOSCALE, 2016, 8 (36) : 16332 - 16339
  • [7] Anti-angiogenic effect of vorinostat (suberoylanilide hydroxamic acid, SAHA), a histone deacetylase inhibitor, in CTCL lesions
    Ni, X.
    Kelly, C.
    Talpur, R.
    Zhang, C.
    Breuer-McHam, J.
    Richon, Vm
    Duvic, M.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 2 - 2
  • [8] Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
    Mottet, D.
    Castronovo, V.
    [J]. CURRENT CANCER DRUG TARGETS, 2010, 10 (08) : 898 - 913
  • [9] Phosphatase inhibitors with anti-angiogenic effect in vitro
    Sylvest, Lene
    Bendiksen, Christine Dam
    Houen, Gunnar
    [J]. APMIS, 2010, 118 (01) : 49 - 59
  • [10] MECHANISMS OF RESISTANCE TO ANTI-ANGIOGENIC KINASE INHIBITORS
    Verheul, H. M. W.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 25 - 25
12345